HQ Ta, H Whitworth, Y Yin, M Conaway, HF Frierson… - Molecular …, 2019 - cir.nii.ac.jp
Discovery of a novel long noncoding RNA overlapping the LCK gene that regulates prostate cancer cell growth | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …
HQ Ta, H Whitworth, Y Yin, M Conaway, HFF Jr… - 2019 - med.virginia.edu
Background: Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castrationresistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin, M Conaway… - Molecular …, 2019 - europepmc.org
Background Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin, M Conaway, HFF Jr… - 2019 - rvaprostatecancersupport.org
Background: Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castrationresistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin… - Molecular …, 2019 - molecular-cancer.biomedcentral …
Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs (lncRNAs) are …
HQ Ta, H Whitworth, Y Yin, M Conaway… - Molecular …, 2019 - search.ebscohost.com
Background: Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin, M Conaway… - Molecular …, 2019 - ncbi.nlm.nih.gov
Background Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin… - Molecular …, 2019 - utsouthwestern.elsevierpure.com
Background: Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs …
HQ Ta, H Whitworth, Y Yin, M Conaway… - Molecular …, 2019 - ohiostate.elsevierpure.com
Background: Virtually all patients with metastatic prostate cancer (PCa) will relapse and develop lethal castration-resistant prostate cancer (CRPC). Long noncoding RNAs …